[ Price : $8.95]
FDA accepts for review a BLA resubmission from Outlook Therapeutics seeking approval of ONS-5010/Lytenava (bevacizumab-vikg) for t...[ Price : $8.95]
Two Mintz attorneys examine what has happened to some of former FDA commissioner Marty Makarys initiatives following his resignati...[ Price : $8.95]
A coalition of 65 health, environmental, consumer, farming, and animal welfare organizations petition FDA to withdraw approvals fo...[ Price : $8.95]
A 6/18 advisory committee meeting is set to review Moderna's investigational mRNA influenza vaccine as the agency posts a briefing...[ Price : $8.95]
FDA says there is an implementation delay for isotretinoin iPLEDGE Risk Evaluation and Mitigation Strategy modif...[ Price : $8.95]
FDA warns Chelmsford, ME-based Zoll Medical about Quality System and Medical Device Reporting violations in its manufacturing of s...[ Price : $8.95]
FDA warns Canadas Sante Manufacturing about CGMP issues found in an agency review of requested records detailing the firms manufac...[ Price : $8.95]
North Dakota State University economist Raymond March faults the way in which FDA provides risk management guidance to regulated c...